Webinar: antibody patents in Europe and beyond

Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application. Antibody experts and European patent attorneys Tom Leonard, Alison Care and Dave Wortley from law firm Kilburn & Strode joined WIPR group editor Tom Phillips for a webinar on the latest developments in antibody patenting yesterday, August 5.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Vir Biotech partners with WuXi on COVID-19 antibody treatment

27 February 2020 Immunology-focused Vir Biotechnology and Hong Kong-based WuXi Biologics have become the latest companies to turn their focus to developing treatments for the novel coronavirus.

Americas

LSIPR webinar: BSKB dissects antibody patents

1 February 2018 When it comes to patenting antibodies, “written description seems to be the big issue these days”, according to Gerald Murphy, IP partner at law firm Birch Stewart Kolasch Birch.

More features

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Webinar: antibody patents in Europe and beyond

More on this story

Editor's picks

Editor's picks

More features